SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
Abstract Introduction One dose of a coronavirus disease 2019 (COVID‐19) vaccine can elicit high antibody titers in individuals who were previously infected by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, it is unclear how a SARS‐CoV‐2 infection shortly after a first COVID‐1...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5902431511f448c2b60cff0972da2504 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Abstract Introduction One dose of a coronavirus disease 2019 (COVID‐19) vaccine can elicit high antibody titers in individuals who were previously infected by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, it is unclear how a SARS‐CoV‐2 infection shortly after a first COVID‐19 vaccine dose affects antibody responses. Methods Here we investigate residents and staff of a nursing home, where a COVID‐19 outbreak occurred shortly after the first BNT162b2 immunization. Results and Conclusions Our data show that individuals who got infected as early as 10 days after their first immunization show antibody levels comparable to fully vaccinated individuals. |
|---|